Recombinant
RabMAb

Anti-Lipocalin-2 / NGAL antibody [EPR5084] (ab125075)

Publishing research using ab125075? Please let us know so that we can cite the reference in this datasheet.

ab125075 has been referenced in 2 publications.

  • Ku AT  et al. TCF7L1 promotes skin tumorigenesis independently of ß-catenin through induction of LCN2. Elife 6:N/A (2017). WB . PubMed: 28467300
  • Wei T  et al. Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation. Sci Rep 6:24378 (2016). WB . PubMed: 27075045

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up